AEPCX
Price
$61.11
Change
-$0.85 (-1.37%)
Updated
Nov 18 closing price
Net Assets
134.2B
AIWCX
Price
$12.67
Change
-$0.15 (-1.17%)
Updated
Nov 18 closing price
Net Assets
2.59B
Interact to see
Advertisement

AEPCX vs AIWCX

Header iconAEPCX vs AIWCX Comparison
Open Charts AEPCX vs AIWCXBanner chart's image
American Funds EUPAC C
Price$61.11
Change-$0.85 (-1.37%)
VolumeN/A
Net Assets134.2B
American Century International Gr C
Price$12.67
Change-$0.15 (-1.17%)
VolumeN/A
Net Assets2.59B
AEPCX vs AIWCX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. AIWCX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and AIWCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 134B vs. AIWCX (2.59B). AEPCX pays higher dividends than AIWCX: AEPCX (0.15) vs AIWCX (0.00). AEPCX was incepted earlier than AIWCX: AEPCX (25 years) vs AIWCX (24 years). AIWCX (2.22) is less costly to investors than AEPCX (1.57). AIWCX is a more actively managed with annual turnover of: 56.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than AIWCX: AEPCX (250) vs AIWCX (2500). AEPCX annual gain was more profitable for investors over the last year : 12.24 vs. AIWCX (11.48). AEPCX return over 5 years is better than : 0.93 vs. AIWCX (-12.12).
AEPCXAIWCXAEPCX / AIWCX
Total Expense Ratio1.572.2271%
Annual Report Gross Expense Ratio1.572.2271%
Fund Existence25 years24 years-
Gain YTD18.27011.965153%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets134B2.59B5,170%
Annual Yield % from dividends0.150.00-
Returns for 1 year12.2411.48107%
Returns for 3 years29.1726.18111%
Returns for 5 years0.93-12.12-8%
Returns for 10 years33.516.98480%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLGZX37.36N/A
N/A
Harding Loevner Global Equity Instl Z
DCCRX27.50N/A
N/A
Macquarie Small Cap Core R
SHPCX14.62N/A
N/A
Saratoga Health & Biotechnology C
OCMAX30.86N/A
N/A
OCM Gold Atlas
MUETX39.38-0.30
-0.76%
MFS Blended Research Core Equity R3